Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer
(Bloomberg Businessweek) September 2, 2010 - People with osteoporosis who take drugs such as Boniva (ibandronate), Fosamax (alendronate) or Actonel (risedronate) to strengthen their bones may be at an increased risk of esophageal cancer, British researchers report.
read article »
Celldex Says Pfizer Ends Cancer Vaccine Deal; Shares Fall
(Reuters) September 3, 2010 - Celldex Therapeutics Inc said its partner Pfizer ended the deal to co-develop Celldex's cancer vaccine, its lead product, as the program was no longer a strategic priority for the drug giant.
read article »
'Major Advance' in Tackling Aggressive Breast Cancer
(Telegraph UK) September 3, 2010 - A breakthrough in understanding how a particularly aggressive form of breast cancer develops could lead to the creation of new drugs which would stop tumours ever developing, scientists hope.
read article »
Hormel Institute Study Reveals Capsaicin Can Act as Cocarcinogen
(University of Minnesota) September 2, 2010 - The September cover story of the nation’s leading cancer journal, “Cancer Research,” features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer.
read press release »
Celgene Seeks to Stop Natco's Generic Revlimid
(Reuters) September 3, 2010 - Celgene Corp said it plans to file a complaint alleging infringement against India's Natco Pharma Ltd, which has submitted a request to the U.S. Food and Drug Administration for authorization to make and sell generic versions of Celgene's cancer drug Revlimid in the United States.
read article »
World of E Cigarettes: American Cancer Society Shuns E Cigarettes in Favor of the Real Thing
(Reuters) September 3, 2010 - The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week.
read article »
China Cooking-Oil Maker Says Cancer-Causing Chemical in Product
(San Francisco Chronicle) September 2, 2010 - Jinhao Camellia Oil Corp., a Chinese maker of cooking oils, said about 42.5 tons of one of its products contained excessive amounts of a cancer-causing chemical.
read article »
Celsion Receives SBIR Grant To Expand Its Technology Platform
(Yahoo! Finance) September 2, 2010 - Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
read article »
Vanderbilt-Ingram Cancer Center Opens Expanded Cancer Clinic
(Vanderbilt-Ingram) September 2, 2010 - Vanderbilt-Ingram Cancer Center has unveiled its newly expanded waiting area and additional clinic examination rooms for cancer patients and their families. The new, 10,000- square- foot space is located on the first floor of The Vanderbilt Clinic, across from the existing Cancer Center reception area.
read press release »
Patient Access and Reimbursement Challenges and Opportunities to be Addressed at AccessMED’s Patient Access Summit
(US Oncology) September 2, 2010 - Today’s healthcare reform environment brings new patient access and reimbursement implications to the pharmaceutical industry.
read press release »
Michael Douglas: 31 Days in the Life of a Throat Cancer Patient
(ABC News) September 3, 2010 - Another throat cancer patient tells of working his way through treatment, side-effects.
read article »
Opinion: Surer Footing for Medicare
(Washington Post) September 3, 2010 - Former health and human services secretary Michael Leavitt was incorrect in calling the Affordable Care Act's Medicare reforms an "illusion" ["The wrong prescription for Medicare," Washington Forum, Aug. 27].
read article (free registration required) »
Novartis Malaria Drug May Yield First New Treatment in 30 Years
(Bloomberg) September 2, 2010 - An experimental Novartis AG medicine that killed drug-resistant malaria in laboratory studies may become the first new class of treatment against the disease in 30 years, researchers said.
read article »
Special Report: Outgunned FDA Tries to Get Tough with Drug Ads
(Reuters) September 3, 2010 - In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol the virtues of Mirena, a birth control device sold by Bayer Healthcare.The nurse was on Bayer's payroll.
read article »
Ads for Sleep Aid, HIV Drug Among Those Warned by FDA
(Reuters) September 3, 2010 - The following are details of some recent FDA warnings sent to drugmakers over misleading or inappropriate advertising, along with the dates the letters were made public.
read article »
Roche to Cut Costs, Review Business After Drug Setbacks
(Reuters) September 3, 2010 - Swiss drugmaker Roche Holding AG will review its business and cut costs to cope with recent setbacks on key drugs and rising pressures on prices from healthcare reforms, it said on Friday.
read article »
Abbott Abandons Plans to Sell Vaccines Business
(New York Times) September 3, 2010 - Drug and medical device firm Abbott Laboratories says it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies.
read article (free registration required) »
© Caribou Publishing. All rights reserved. 3001 Bridgeway, Suite #K124, Sausalito, CA 94965
Contact Us